Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
2.
Chinese Journal of Lung Cancer ; (12): 63-66, 2018.
Artigo em Inglês | WPRIM | ID: wpr-776376

RESUMO

Resistance to cancer therapy continues to be a major limitation for the successful treatment of cancer. There are many published studies on therapy resistance in breast and prostate cancers; however, there are currently no data on molecular markers associated with resistance. The conflicting data were reported regarding the AKT/m-TOR signaling pathway components as markers predicting resistance. The AKT/m-TOR signaling pathway is involved in the development of many human cancers; its activation is related to cell proliferation, angiogenesis, apoptosis, as well as to therapy resistance. Molecular alterations in the AKT/m-TOR signaling pathway provide a platform to identify universal markers associated with the development of resistance to cancer therapy.


Assuntos
Animais , Humanos , Biomarcadores Tumorais , Metabolismo , Resistencia a Medicamentos Antineoplásicos , Terapia de Alvo Molecular , Métodos , Neoplasias , Tratamento Farmacológico , Metabolismo , Patologia , Proteínas Proto-Oncogênicas c-akt , Metabolismo , Transdução de Sinais , Serina-Treonina Quinases TOR , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA